Skip to main content

Table 4 HCV support services and treatment provided onsite at DCRs/SIFs and availability of HCV treatment to DCR clients

From: Drug consumption rooms (DCRs) as a setting to address hepatitis C – findings from an international online survey

  Provide onsite Plan to expand in future
HCV support (multiple responses possible) n = 46 n = 47
 Yes, referral to other services that can provide HCV treatment 96% 36%
 Yes, disease self-management support (e.g. healthy diet, obesity) 50% 15%
 Yes, liver health/cirrhosis monitoring (e.g. fibro-scan, blood test) 24% 11%
 No 15% 49%
HCV treatment (one response only) n = 48 n = 39
 Yes, new HCV treatment forms (DAAs) 4% 3%
 Yes, interferon-based treatment 0% 3%
 Yes, both treatment options 4% 0%
 Other (provided details) 10%
 Don’t know 8%
 No 86% 84%